Skip to main content

Table 1 Baseline characteristics of patients

From: Safety profile and risk factors for bleeding in transbronchial cryobiopsy using a two-scope technique for peripheral pulmonary lesions

Variable

N = 139 (100%)

Age (years)

72 (20–88)

Male

88 (63.3)

Body height (cm)

159.8 (140.0–182.6)

Body mass index (kg/m2)

22.6 (14.4–34.4)

Diameter of the lesion (mm)

25.8 (8.7–72.7)

Related bronchial generation into the PPL, generations

5 (3–8)

Lobar position

 Right upper lobe/left upper segment

70 (50.4)

 Right middle/left lingula

17 (12.2)

 Right lower/left lower

52 (37.4)

Location area

 Outer area

86 (61.8)

 Inner area

53 (38.1)

Lesion appearance on CT

 Solid nodule

103 (74.1)

 GGN

36 (25.9)

Bronchus sign on CT

 Positive

104 (74.8)

 Negative

35 (25.2)

Bronchoscope type for Biopsy

 Thin scope

91 (65.5)

 Thick scope

48 (34.5)

Respiratory comorbidities

 Chronic obstructive pulmonary disease

16 (11.5)

 Interstitial lung disease

6 (4.3)

 Bronchial asthma

6 (4.3)

Use of bridging anticoagulation therapy

5 (3.6)

Coagulation profile

 PT-INR

0.97 (0.87–1.17)

 PTT (s)

25.9 (20.0–37.2)

 Thrombocytes (× 103/μL)

239 (113–524)

  1. Data are presented as median (range) or n (%) values
  2. PPL peripheral pulmonary lesion, GGN ground-glass nodule, PT-INR prothrombin time international normalized ratio, PTT partial thromboplastin time